Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
CTXR
CITIUS PHARMACEUTICALS INC
$6.45MN/A0.00%N/AN/AN/AN/A
VOR
VOR BIOPHARMA INC
$18.85MN/A0.00%N/AN/AN/AN/A
BTAI
BIOXCEL THERAPEUTICS INC
$8.39MN/A0.00%N/AN/AN/AN/A
PALI
PALISADE BIO INC
$3.32MN/A0.00%N/AN/AN/AN/A
IMNN
IMUNON INC
$11.70MN/A0.00%N/AN/AN/AN/A
GBIO
GENERATION BIO CO
$24.13MN/A0.00%N/AN/AN/AN/A
PASG
PASSAGE BIO INC
$20.45MN/A0.00%N/AN/AN/AN/A
INAB
IN8BIO INC
$14.25MN/A0.00%N/AN/AN/AN/A
XFOR
X4 PHARMACEUTICALS INC
$19.51MN/A0.00%N/AN/AN/AN/A
TNYA
TENAYA THERAPEUTICS INC
$67.34MN/A0.00%N/AN/AN/AN/A
ACRV
ACRIVON THERAPEUTICS INC
$36.37MN/A0.00%N/AN/AN/AN/A
PSTV
PLUS THERAPEUTICS INC
$11.22MN/A0.00%N/AN/AN/AN/A
OKUR
ONKURE THERAPEUTICS INC
$25.94MN/A0.00%N/AN/AN/AN/A
ANVS
ANNOVIS BIO INC
$29.81MN/A0.00%N/AN/AN/AN/A
CODX
CO-DIAGNOSTICS INC
$11.46MN/A0.00%N/AN/AN/AN/A
FBLG
FIBROBIOLOGICS INC
$31.36MN/A0.00%N/AN/AN/AN/A
HUMA
HUMACYTE INC
$184.59MN/A0.00%N/AN/AN/AN/A
INZY
INOZYME PHARMA INC
$73.88MN/A0.00%N/AN/AN/AN/A
CLNN
CLENE INC
$23.62MN/A0.00%N/AN/AN/AN/A
ANNX
ANNEXON INC
$175.54MN/A0.00%N/AN/AN/AN/A
AFMD
AFFIMED NV
$11.23MN/A0.00%N/AN/AN/AN/A
NRXP
NRX PHARMACEUTICALS INC
$34.51MN/A0.00%N/AN/AN/AN/A
IMRX
IMMUNEERING CORP
$41.02MN/A0.00%N/AN/AN/AN/A
IGC
IGC PHARMA INC
$23.75MN/A0.00%N/AN/AN/AN/A
AMTX
AEMETIS INC
$71.43MN/A0.00%N/AN/AN/AN/A
CANF
CAN-FITE BIOPHARMA LTD
$9.93MN/AN/AN/AN/AN/AN/A
INTS
INTENSITY THERAPEUTICS INC
$8.18MN/A0.00%N/AN/AN/AN/A
FBIO
FORTRESS BIOTECH INC
$49.91MN/A0.00%N/AN/AN/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$41.96MN/A0.00%N/AN/AN/AN/A
KAPA
KAIROS PHARMA LTD
$11.37MN/A0.00%N/AN/AN/AN/A
CYBN
CYBIN INC
$141.01MN/A0.00%N/AN/AN/AN/A
OVID
OVID THERAPEUTICS INC
$20.61MN/A0.00%N/AN/AN/AN/A
CABA
CABALETTA BIO INC
$60.38MN/A0.00%N/AN/AN/AN/A
IVVD
INVIVYD INC
$77.50MN/A0.00%N/AN/AN/AN/A
CGTX
COGNITION THERAPEUTICS INC
$18.66MN/A0.00%N/AN/AN/AN/A
GOVX
GEOVAX LABS INC
$14.10MN/A0.00%N/AN/AN/AN/A
JSPR
JASPER THERAPEUTICS INC
$67.90MN/A0.00%N/AN/AN/AN/A
OCGN
OCUGEN INC
$195.65MN/A0.00%N/AN/AN/AN/A
SNSE
SENSEI BIOTHERAPEUTICS INC
$9.07MN/A0.00%N/AN/AN/AN/A
IMUX
IMMUNIC INC
$91.05MN/A0.00%N/AN/AN/AN/A
HOWL
WEREWOLF THERAPEUTICS INC
$35.90MN/A0.00%N/AN/AN/AN/A
PRME
PRIME MEDICINE INC
$170.68MN/A0.00%N/AN/AN/AN/A
APLT
APPLIED THERAPEUTICS INC
$56.63MN/A0.00%N/AN/AN/AN/A
FDMT
4D MOLECULAR THERAPEUTICS INC
$142.68MN/A0.00%N/AN/AN/AN/A
CARM
CARISMA THERAPEUTICS INC
$7.98MN/A0.00%$0.3615N/AN/A0
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$38.33MN/A0.00%N/AN/AN/AN/A
CBUS
CIBUS INC
$73.68MN/A0.00%N/AN/AN/AN/A
UNCY
UNICYCIVE THERAPEUTICS INC
$65.84MN/A0.00%N/AN/AN/AN/A
ENLV
ENLIVEX THERAPEUTICS LTD
$24.12MN/A0.00%N/AN/AN/AN/A
ARTV
ARTIVA BIOTHERAPEUTICS INC
$50.68MN/A0.00%N/AN/AN/AN/A
LCTX
LINEAGE CELL THERAPEUTICS INC
$100.48MN/A0.00%N/AN/AN/AN/A
FEMY
FEMASYS INC
$28.87MN/A0.00%N/AN/AN/AN/A
ZURA
ZURA BIO LTD
$74.87MN/A0.00%N/AN/AN/AN/A
RAPT
RAPT THERAPEUTICS INC
$99.61MN/A0.00%N/AN/AN/AN/A
MGX
METAGENOMI INC
$56.45MN/A0.00%N/AN/AN/AN/A
OSTX
OS THERAPIES INC
$42.24MN/A0.00%N/AN/AN/AN/A
TNGX
TANGO THERAPEUTICS INC
$123.24MN/A0.00%N/AN/AN/AN/A
DTIL
PRECISION BIOSCIENCES INC
$53.77MN/A0.00%N/AN/AN/AN/A
GNLX
GENELUX CORP
$111.70MN/A0.00%N/AN/AN/AN/A
IPA
IMMUNOPRECISE ANTIBODIES LTD
$14.75MN/A0.00%N/AN/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$104.96MN/A0.00%N/AN/AN/AN/A
MRKR
MARKER THERAPEUTICS INC
$12.42MN/A0.00%N/AN/AN/AN/A
SLN
SILENCE THERAPEUTICS PLC
$174.56MN/A0.00%N/AN/AN/AN/A
IOVA
IOVANCE BIOTHERAPEUTICS INC
$584.39MN/A0.00%N/AN/AN/AN/A
ATOS
ATOSSA THERAPEUTICS INC
$105.53MN/A0.00%N/AN/AN/AN/A
CRBU
CARIBOU BIOSCIENCES INC
$71.99MN/A0.00%N/AN/AN/AN/A
KPTI
KARYOPHARM THERAPEUTICS INC
$50.58MN/A0.00%N/AN/AN/AN/A
ELEV
ELEVATION ONCOLOGY INC
$20.31MN/A0.00%N/AN/AN/AN/A
ACRS
ACLARIS THERAPEUTICS INC
$136.43MN/A0.00%N/AN/AN/AN/A
CMPX
COMPASS THERAPEUTICS INC
$251.67MN/A0.00%N/AN/AN/AN/A
AVTX
AVALO THERAPEUTICS INC
$43.33MN/A0.00%N/AN/AN/AN/A
ALXO
ALX ONCOLOGY HOLDINGS INC
$22.55MN/A0.00%N/AN/AN/AN/A
ONCY
ONCOLYTICS BIOTECH INC
$41.53MN/A0.00%N/AN/AN/AN/A
PDSB
PDS BIOTECHNOLOGY CORP
$54.48MN/A0.00%N/AN/AN/AN/A
LRMR
LARIMAR THERAPEUTICS INC
$135.74MN/A0.00%N/AN/AN/AN/A
BDTX
BLACK DIAMOND THERAPEUTICS INC
$92.93MN/A0.00%N/AN/AN/AN/A
CRBP
CORBUS PHARMACEUTICALS HOLDINGS INC
$78.93MN/A0.00%N/AN/AN/AN/A
ESPR
ESPERION THERAPEUTICS INC
$158.16MN/A0.00%N/AN/AN/AN/A
ADVM
ADVERUM BIOTECHNOLOGIES INC
$58.70MN/A0.00%N/AN/AN/AN/A
SPRO
SPERO THERAPEUTICS INC
$34.66MN/A0.00%N/AN/AN/AN/A
SKYE
SKYE BIOSCIENCE INC
$56.08MN/A0.00%N/AN/AN/AN/A
ALLO
ALLOGENE THERAPEUTICS INC
$252.03MN/A0.00%N/AN/AN/AN/A
NKTR
NEKTAR THERAPEUTICS
$109.62MN/A0.00%N/AN/AN/AN/A
GRI
GRI BIO INC
$772.28kN/A0.00%N/AN/AN/AN/A
ATYR
ATYR PHARMA INC
$291.93MN/A0.00%N/AN/AN/AN/A
CAPR
CAPRICOR THERAPEUTICS INC
$289.59MN/A0.00%N/AN/AN/AN/A
LXEO
LEXEO THERAPEUTICS INC
$89.30MN/A0.00%N/AN/AN/AN/A
CNTX
CONTEXT THERAPEUTICS INC
$70.06MN/A0.00%N/AN/AN/AN/A
ABOS
ACUMEN PHARMACEUTICALS INC
$59.36MN/A0.00%N/AN/AN/AN/A
CING
CINGULATE INC
$17.03MN/A0.00%N/AN/AN/AN/A
NKTX
NKARTA INC
$136.95MN/A0.00%N/AN/AN/AN/A
KYTX
KYVERNA THERAPEUTICS INC
$91.18MN/A0.00%N/AN/AN/AN/A
BMEA
BIOMEA FUSION INC
$61.24MN/A0.00%N/AN/AN/AN/A
ATAI
ATAI LIFE SCIENCES NV
$275.65MN/A0.00%N/AN/AN/AN/A
QNCX
QUINCE THERAPEUTICS INC
$44.88MN/A0.00%N/AN/AN/AN/A
VNRX
VOLITIONRX LTD
$48.27MN/A0.00%N/AN/AN/AN/A
ENGN
ENGENE HOLDINGS INC
$150.89MN/A0.00%N/AN/AN/AN/A
LGVN
LONGEVERON INC
$20.11MN/A0.00%N/AN/AN/AN/A
IPSC
CENTURY THERAPEUTICS INC
$46.21MN/A0.00%N/AN/AN/AN/A
TCRX
TSCAN THERAPEUTICS INC
$71.87MN/A0.00%N/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.